“COMPARISON OF RITUXIMAB, AZATHIOPRINE AND MYCOPHENOLATE MOFETIL IN THE MANAGEMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS: A SYSTEMATIC REVIEW”, RECIMA21, vol. 6, no. 5, p. e656373, May 2025, doi: 10.47820/recima21.v6i5.6373.